Shares of Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) have earned a consensus recommendation of “Hold” from the six analysts that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.1875.
A number of analysts have commented on the stock. Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Roth Capital reaffirmed a “buy” rating and issued a $5.75 price target on shares of Aspen Aerogels in a research report on Friday, May 8th. Finally, Barclays boosted their price objective on shares of Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a report on Monday, May 11th.
Get Our Latest Research Report on ASPN
Institutional Inflows and Outflows
Aspen Aerogels Price Performance
NYSE ASPN opened at $5.15 on Friday. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.78. The firm has a market capitalization of $427.15 million, a PE ratio of -3.79 and a beta of 2.98. The company’s 50 day simple moving average is $5.68 and its 200 day simple moving average is $4.31. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 2.54.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The firm had revenue of $37.88 million during the quarter, compared to analyst estimates of $36.58 million. During the same quarter last year, the company earned ($0.06) EPS. The company’s quarterly revenue was down 51.8% compared to the same quarter last year. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, equities research analysts forecast that Aspen Aerogels will post -0.8 EPS for the current fiscal year.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
See Also
- Five stocks we like better than Aspen Aerogels
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
